1 minute read

Contents

What’s inside

05 Message from the Chair, Professor Ian Davis07 CEO Update09 Consumer Advisory Panel (CAP) Update11 Kev’s Crew13 Friends of ANZUP14 Finding a clinical pathway during a pandemic17 Meet Associate Professor Arun Azad19 Spotlight on prostate cancer

21 ANZUP’s ENZAMET trial is awarded all three of ACTA’s Trial of the Year Awards

23 Advanced Prostate Cancer Consensus Conference (APCCC): Asia-Pacific (APAC) Satellite Symposium

24 Worldwide prostate cancer trial continues to strongly recruit

25 Where are we in demonstrating economic value in prostate cancer trials...

26 The role of the Prostate Cancer Subcommittee28 ANZUP trials – prostate32 Spotlight on bladder and urothelial cancer34 In the Media...

36 The importance of data to improve patient outcomes with bladder cancer

37 ANZUP trials – bladder

ANZUP Cancer Trials Group Limited

Registered office Level 6 Lifehouse Building 119-143 Missenden Road Camperdown NSW 2050

T: +61 2 9562 5042 F: +61 2 9562 5008 www.anzup.org.au

@ANZUPtrials / @BelowTheBeltANZ ANZUPtrials / BelowTheBeltCancer ANZUP @ANZUPtrials ANZUP Cancer Trials Group

ACN 133 634 956 ABN 32 133 634 956

39 Recruitment nearing completion for world first trial for bladder cancer

40 Spotlight on testicular cancer42 Testicular Cancer Research Highlights44 ANZUP trials – testicular46 Spotlight on kidney cancer48 Kidney Cancer and Immunotherapy49 A pilot study for Kidney Cancer50 ANZUP trials – kidney52 Spotlight on penile cancer

54 What are the barriers and facilitators to interdisciplinary models of person-centred supportive care in the context of penile cancer? A mixed methods study...

56 Trials in follow up59 2020 Below the Belt Research Fund Recipients61 How can you get involved?

62 ANZUP registers with workplace-giving platform Good2Give

63 Get inspired and host your own63 How does your donation make a difference?64 Below the belt #YourWay69 Fundraising heroes

75 Thanks to Corporate Supporters and In-Kind Supporters

4 A LITTLE BELOW THE BELT

This article is from: